ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$NTLA:NASDAQ · INTELLIA THERAPEUTICS INC

Sector: health

Conviction from: NASDAQ

52-week range: 7.9518.48

CRISPR gene-editing therapeutics developer

3 tracked filer(s) hold this · 1 opened, 0 added, 2 trimmed in 30-SEP-2026

Aggregate 13FScore 64 — mean of 3 scored holder(s) · buyers (new/add) avg 55. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Bridgewater55New buy137,158$1,654,1250.0%
Paul Tudor Jones / Tudor61Trimmed -40%78,031$941,0540.0%
Steve Cohen / Point7275Trimmed -78%116,700$1,407,4020.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-01-07Cohen Fred Edirector150,000$1,402,500Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.